ArticleCureus2025
Pre-existing Corticosteroid Use Predicts Worse Outcomes in Major Trauma.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective Corticosteroids are one of the most commonly prescribed medications in the United States (U.S.), typically used for their benefits in autoimmune and inflammatory conditions. Major trauma (Injury Severity Score [ISS] >15) is a leading cause of death among young adults and is associated with increased mortality in the elderly population. In this study, we aimed to examine the association between pre-injury corticosteroid use and clinical outcomes in adults experiencing a major trauma event. Methods Patients (aged ≥18 years) admitted to U.S. Level 1 or 2 trauma centers for major trauma were selected retrospectively from the National Trauma Data Bank (2019-2021). Regression analysis was employed to determine the association between pre-existing corticosteroid use status and complications, including in-hospital mortality, adjusting for age, gender, ISS, and Revised Trauma Score (RTS). Results We identified 348,202 patients, of whom 0.8% (n = 2,733) had prior steroid use; 243,722 were males (70%), and the mean age was 51 years. Steroid use increased the odds of acute kidney injury (AKI) (adjusted odds ratio [aOR] = 1.4, p = 0.011), acute respiratory distress syndrome (ARDS) (aOR = 1.9, p<0.001), cerebrovascular accident (CVA) (aOR = 1.6, p = 0.003), unplanned intubation (aOR = 1.6, p<0.001), and in-hospital mortality (aOR = 1.5, p<0.001). Patients with pre-existing steroid use had a higher incidence of AKI (58 [2.1%] vs. 5,046 [1.5%]), ARDS (31 [1.1%] vs. 2,915 [0.9%]), CVA (41 [1.5%] vs. 2,788 [0.8%]), unplanned intubation (170 [6.3%] vs. 10,886 [3.3%]), and in-hospital mortality (428 [15.7%] vs. 37,014 [11.1%]) compared to their counterparts. Conclusions Corticosteroid usage before major trauma is a significant predictor of poorer outcomes and in-hospital mortality. Providers must factor this information into the management of patients on corticosteroid therapy who are at high risk of or have experienced major trauma.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.